- Home
- BFLY vs REPL Comparison
BFLY vs REPL Comparison
Compare BFLY & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFLY
- REPL
- Stock Information
- Founded
- BFLY 2011
- REPL 2015
- Country
- BFLY United States
- REPL United States
- Employees
- BFLY N/A
- REPL N/A
- Industry
- BFLY Medical Electronics
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- BFLY Health Care
- REPL Health Care
- Exchange
- BFLY Nasdaq
- REPL Nasdaq
- Market Cap
- BFLY 750.0M
- REPL 897.3M
- IPO Year
- BFLY N/A
- REPL 2018
- Fundamental
- Price
- BFLY $3.07
- REPL $12.49
- Analyst Decision
- BFLY
- REPL Strong Buy
- Analyst Count
- BFLY 0
- REPL 6
- Target Price
- BFLY N/A
- REPL $17.50
- AVG Volume (30 Days)
- BFLY 3.4M
- REPL 1.3M
- Earning Date
- BFLY 11-01-2024
- REPL 02-06-2025
- Dividend Yield
- BFLY N/A
- REPL N/A
- EPS Growth
- BFLY N/A
- REPL N/A
- EPS
- BFLY N/A
- REPL N/A
- Revenue
- BFLY $76,221,000.00
- REPL N/A
- Revenue This Year
- BFLY $24.93
- REPL N/A
- Revenue Next Year
- BFLY $18.11
- REPL $300.41
- P/E Ratio
- BFLY N/A
- REPL N/A
- Revenue Growth
- BFLY 11.49
- REPL N/A
- 52 Week Low
- BFLY $0.67
- REPL $4.92
- 52 Week High
- BFLY $3.78
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- BFLY 48.66
- REPL 50.53
- Support Level
- BFLY $3.28
- REPL $11.19
- Resistance Level
- BFLY $3.77
- REPL $12.79
- Average True Range (ATR)
- BFLY 0.32
- REPL 0.70
- MACD
- BFLY -0.09
- REPL -0.14
- Stochastic Oscillator
- BFLY 31.07
- REPL 52.21
About BFLY Butterfly Network Inc.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.